Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-Based Payment Transactions (Details) - Schedule of share options, their weighted average exercise price

v3.23.1
Share-Based Payment Transactions (Details) - Schedule of share options, their weighted average exercise price - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Share Options Their Weighted Average Exercise Price Abstract    
Number of options, Outstanding, at beginning of year 18,422,700  
Weighted average exercise price beginning of year $ 0.18  
Weighted average remaining contractual terms (in years) beginning of year 8 years 5 months 12 days  
Aggregate intrinsic value beginning of year  
Number of options, Vested and expected to vest 27,002,200  
Weighted average exercise price, Vested and expected to vest $ 0.13  
Weighted average remaining contractual terms (in years), Vested and expected to vest 7 years 1 month 20 days  
Aggregate intrinsic value, Vested and expected to vest  
Number of options, Exercisable 11,071,575  
Weighted average exercise price, Exercisable $ 0.21  
Weighted average remaining contractual terms (in years), Exercisable 7 years 2 months 4 days  
Aggregate intrinsic value, Exercisable  
Number of options, Grants 8,750,000  
Weighted average exercise price, Grants $ 0.07  
Weighted average remaining contractual terms (in years), Grants 2 years 8 months 23 days
Aggregate intrinsic value, Grants  
Number of options, Forfeited/expired (170,500)  
Weighted average exercise price, Forfeited/expired $ 0.54  
Weighted average remaining contractual terms (in years), Forfeited/expired  
Aggregate intrinsic value, Forfeited/expired  
Number of options, Outstanding, at end of year 27,002,200 18,422,700
Weighted average exercise price end of year $ 0.13 $ 0.18
Weighted average remaining contractual terms (in years) end of year 7 years 1 month 20 days  
Aggregate intrinsic value end of year